As anti-obesity drug prices soar, how employers can navigate difficult choices

Human Resource ExecutiveJeff Levin-Scherz, Chantell SellNovember 30, 2023

New anti-obesity drugs create an inescapable dilemma for companies that offer health insurance.

Read more at Human Resource Executive

Topics: National, Employer-Based Coverage

Related headlines

Report: Global Healthcare Benefit Costs Expected to Rise 9.9% in 2024

MedCity News11/29/2023

The high cost of American healthcare, in 3 charts.

Advisory Board10/30/2023

Health Insurance Costs Are Squeezing Workers and Employers

American Progress11/29/2022